Institution
Hospital General Universitario Gregorio Marañón
Healthcare•Madrid, Spain•
About: Hospital General Universitario Gregorio Marañón is a healthcare organization based out in Madrid, Spain. It is known for research contribution in the topics: Population & Transplantation. The organization has 11975 authors who have published 12386 publications receiving 244847 citations.
Topics: Population, Transplantation, Medicine, Myocardial infarction, Cancer
Papers published on a yearly basis
Papers
More filters
••
University of Birmingham1, University of Cambridge2, Imperial College London3, Dresden University of Technology4, University of Geneva5, University of Padua6, Hannover Medical School7, Charité8, Université catholique de Louvain9, Necker-Enfants Malades Hospital10, University of Milan11, Hospital General Universitario Gregorio Marañón12, University of Erlangen-Nuremberg13, University of Brescia14, University of Porto15, London Bridge Hospital16
TL;DR: In this article, the authors report consensus statements that were developed in six important areas: classification of patients with lupus erythematosus, how classification affects the selection of treatment options and definitions of induction, response, flare and maintenance.
Abstract: Systemic lupus erythematosus (SLE) is a complex, multisystem autoimmune disorder, which often involves referral to multiple medical specialists. Lupus nephritis (LN) occurs in ~35% of adults with SLE and predicts poor survival. There is currently no consensus on how to manage patients with SLE or LN across specialties and across different European countries. The Lupus Nephritis Terminology Advisory Group was formed to address this issue as it impacts upon LN treatment. It has developed consensus statements based on opinions from expert panel meetings with nephrologists, nephropathologists, rheumatologists, clinical immunologists and internal medicine specialists from many European countries, after reviewing current guidelines from the European League Against Rheumatism, the American College of Rheumatology and the participants' experience. In this article, we report consensus statements that were developed in six important areas: classification of patients with LN, how classification affects the selection of treatment options and definitions of induction, response, flare and maintenance. We have also proposed a consensus for the terminology involved in the management of LN that is consistent with clinical opinion gathered from multidisciplinary expert meetings and with existing guidelines. We believe this consensus approach provides agreed expert opinion to clinicians and will form the basis for optimising LN treatment.
129 citations
••
University of Parma1, University College London2, Leiden University Medical Center3, Johns Hopkins University4, University of Bordeaux5, University of Tübingen6, Hospital General Universitario Gregorio Marañón7, University of Bologna8, University of Miami9, Université de Sherbrooke10, Medical Research Council11, University of Arizona12, University of Innsbruck13, University of Tampere14, Brighton and Sussex Medical School15, Pompeu Fabra University16, VU University Medical Center17, Université libre de Bruxelles18, Katholieke Universiteit Leuven19, University of Birmingham20, Leipzig University21, Pierre-and-Marie-Curie University22, KAIST23, University of Wisconsin–Milwaukee24, Karolinska University Hospital25, University of Córdoba (Spain)26, St. Jude Children's Research Hospital27
TL;DR: The attendees of the 4th International Workshop on "CMV & Immunosenescence", held in Parma, Italy, 25-27th March, 2013, presented and discussed data related to these open questions, which are reported in this commentary.
129 citations
••
TL;DR: The Spanish Post‐Heart‐Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003), and the influence of antiviral prophylaxis was investigated.
129 citations
••
TL;DR: Spectral analysis of body surface recordings during AF allows a noninvasive characterization of the global distribution of the atrial DFs and the identification of theatrium with the highest frequency, opening the possibility for improved nonin invasive personalized diagnosis and treatment.
Abstract: Background—Ablation of high-frequency sources in patients with atrial fibrillation (AF) is an effective therapy to restore sinus rhythm. However, this strategy may be ineffective in patients withou...
128 citations
••
Autonomous University of Madrid1, Katholieke Universiteit Leuven2, Aarhus University Hospital3, University of Padua4, Rabin Medical Center5, Catholic University of the Sacred Heart6, Shaare Zedek Medical Center7, Beaumont Hospital8, Carlos III Health Institute9, Humanitas University10, Tel Aviv University11, Hospital Clínico San Carlos12, Hospital General Universitario Gregorio Marañón13, University of Milan14, Hospital Sant Joan de Déu Barcelona15
TL;DR: In utero exposure to anti-TNFα drugs does not seem to be associated with increased short-term or long-term risk of severe infections in children.
128 citations
Authors
Showing all 12014 results
Name | H-index | Papers | Citations |
---|---|---|---|
David H. Adams | 155 | 1613 | 117783 |
Stefanie Dimmeler | 147 | 574 | 81658 |
Stuart J. Pocock | 145 | 684 | 143547 |
M. I. Martínez | 134 | 1251 | 79885 |
Guy A. Rouleau | 129 | 884 | 65892 |
Jose L. Jimenez | 124 | 654 | 64226 |
Antoni Torres | 120 | 1238 | 65049 |
Paul P. Tak | 112 | 591 | 57689 |
Luis A. Diaz | 111 | 596 | 75036 |
Frans Van de Werf | 109 | 747 | 63537 |
José Luis Zamorano | 105 | 695 | 133396 |
Francisco Sánchez-Madrid | 102 | 527 | 43418 |
Francesco Locatelli | 99 | 820 | 42454 |
Roberto M. Lang | 96 | 823 | 56638 |
Carlos Simón | 95 | 589 | 31147 |